Schedule 13G ownership disclosure

Cytokinetics Inc

COMMON STOCK · CUSIP: 23282W605

Event date: 2025-12-31

Filing-level shares
17,716,372
Percent of class
14.5%
  • T. Rowe Price Investment Management, Inc.

    Shares: 17,716,372 · Class: 14.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001897612-26-000261
Form type
SCHEDULE 13G/A
Filer
CYTOKINETICS INC
CIK
CIK 1061983
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub